Oncogenic potential of BMI1: race-based evidence in prostate cancer

A recent publication by Ganaie et al. (1) in Clinical Cancer Research (doi: 10.1158/1078-0432.CCR-18-1394, 2018) demonstrate BMI1 as a potential driver of metastasis in prostate cancer. The authors validate the significance of BMI1 in prostate cancer metastasis in African-American and Caucasian-American patients.